PGNX
AQR Capital Management’s Progenics Pharmaceuticals Inc PGNX Stock Holding History
| Quarter | Market Value | Status | Shares |
Shares Change % | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2017
Q4 | – | Sell |
-18,012
| Closed | -$133K | – | 2301 |
|
|
2017
Q3 | $133K | Sell |
18,012
-31,720
| -64% | -$234K | ﹤0.01% | 2212 |
|
|
2017
Q2 | $338K | Hold |
49,732
| – | – | ﹤0.01% | 2007 |
|
|
2017
Q1 | $469K | Buy |
+49,732
| New | +$469K | ﹤0.01% | 1908 |
|
|
2016
Q1 | – | Sell |
-28,144
| Closed | -$173K | – | 2319 |
|
|
2015
Q4 | $173K | Sell |
28,144
-55,733
| -66% | -$343K | ﹤0.01% | 2174 |
|
|
2015
Q3 | $480K | Sell |
83,877
-15,533
| -16% | -$88.9K | ﹤0.01% | 1734 |
|
|
2015
Q2 | $742K | Buy |
99,410
+36,510
| +58% | +$273K | ﹤0.01% | 1638 |
|
|
2015
Q1 | $376K | Buy |
62,900
+28,300
| +82% | +$169K | ﹤0.01% | 1796 |
|
|
2014
Q4 | $262K | Buy |
+34,600
| New | +$262K | ﹤0.01% | 2263 |
|
|
2014
Q3 | – | Sell |
-18,100
| Closed | -$78K | – | 2623 |
|
|
2014
Q2 | $78K | Sell |
18,100
-42,600
| -70% | -$184K | ﹤0.01% | 2480 |
|
|
2014
Q1 | $248K | Buy |
60,700
+3,200
| +6% | +$13.1K | ﹤0.01% | 2351 |
|
|
2013
Q4 | $306K | Buy |
+57,500
| New | +$306K | ﹤0.01% | 2288 |
|
|
2013
Q3 | – | Sell |
-250,000
| Closed | -$1.12M | – | 2559 |
|
|
2013
Q2 | $1.12M | Buy |
+250,000
| New | +$1.12M | ﹤0.01% | 1519 |
|